Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03187938 · ClinicalTrials.gov registry record
Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 292
- Enrollment target
NCT03187938 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 292 participants.
The verdict
NCT03187938 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 292 participants
- Enrollment target
Study Summary
Alkaline phosphatase is known to be produced by syncytiotrophoblasts in the placenta and its levels are normally increased in pregnancy. Therefore, it would be reasonable to hypothesize that alkaline phosphatase would be low to low normal in cases of low birth weight / intrauterine growth restriction (IUGR)/ placental insufficiency.
Interventions
- DIAGNOSTIC_TEST Testing of Alkaline Phosphatase Levels
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 292 participants |
| Start Date | 2017-06-14 |
| Est. Completion | 2019-08-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03187938
The ClinicalTrials.gov registry entry for NCT03187938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 292 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is TriHealth, which has 81 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Testing of Alkaline Phosphatase Levels is the first listed.
NCT03187938 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03187938 about?
NCT03187938 is a clinical study titled "Alkaline Phosphatase Level in Pregnancy and Its Association With Birth Weight". Alkaline phosphatase is known to be produced by syncytiotrophoblasts in the placenta and its levels are normally increased in pregnancy. Therefore, it would be reasonable to hypothesize that alkaline phosphatase would be low to low normal in cases of low birth weight / intrauterine growth restrictio...
What is the current status of trial NCT03187938?
This trial is currently completed. The enrollment target is 292 participants. The study started on 2017-06-14. Estimated completion is 2019-08-05.
What interventions are being tested in trial NCT03187938?
The interventions under investigation include: Testing of Alkaline Phosphatase Levels (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03187938?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.